Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up(legacy) | 92 |
| Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up(legacy) | 74 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up | 0 | 5 | 3 | 2 | 2 | 3 | 0 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 58 |
| China | 14 |
| France | 9 |
| Netherlands | 8 |
| Australia | 6 |
| Vietnam | 6 |
| United Kingdom | 2 |
| Hong Kong SAR China | 2 |
| Ireland | 2 |
| EU | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 24 |
| Rotterdam | 8 |
| Fairfield | 7 |
| Hanoi | 6 |
| Kaleen | 5 |
| Des Moines | 4 |
| Zhengzhou | 4 |
| Cambridge | 3 |
| Beijing | 2 |
| Central | 2 |